Target
Ubiquitin-like modifier-activating enzyme ATG7
Ligand
BDBM476100
Substrate
n/a
Meas. Tech.
Enzyme Assay
IC50
35±n/a nM
Citation
 Adhikari, SCalderwood, EFEngland, DBGould, AEHarrison, SJHuang, SMa, L ATG7 inhibitors and the uses thereof US Patent  US10865208 Publication Date 12/15/2020 
Target
Name:
Ubiquitin-like modifier-activating enzyme ATG7
Synonyms:
APG7-like | APG7L | ATG12-activating enzyme E1 ATG7 | ATG7 | ATG7_HUMAN | Autophagy-related protein 7 | Ubiquitin-activating enzyme E1-like protein | hAGP7
Type:
PROTEIN
Mol. Mass.:
77955.74
Organism:
Homo sapiens (Human)
Description:
ChEMBL_939703
Residue:
703
Sequence:
MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI
  
Inhibitor
Name:
BDBM476100
Synonyms:
US10865208, Compound I-155 | {(2R,3R,4S,5R)-5-[4-amino-3-(benzylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate
Type:
Small organic molecule
Emp. Form.:
C17H19FN6O5S2
Mol. Mass.:
470.498
SMILES:
Nc1ncnc2n(nc(SCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F |r|
Structure:
Search PDB for entries with ligand similarity: